BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9702120)

  • 1. [Apoptosis--programmed cell death].
    Borner M
    Ther Umsch; 1998 Jul; 55(7):459-61. PubMed ID: 9702120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
    Luu Y; Bush J; Cheung KJ; Li G
    Exp Cell Res; 2002 Jun; 276(2):214-22. PubMed ID: 12027451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
    Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the p53 gene.
    Sidransky D; Hollstein M
    Annu Rev Med; 1996; 47():285-301. PubMed ID: 8712782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling.
    Li L; Abdel Fattah E; Cao G; Ren C; Yang G; Goltsov AA; Chinault AC; Cai WW; Timme TL; Thompson TC
    Cancer Res; 2008 Jan; 68(2):434-43. PubMed ID: 18199537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and metabolism: Inside the TIGAR.
    Green DR; Chipuk JE
    Cell; 2006 Jul; 126(1):30-2. PubMed ID: 16839873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53: 25 years of research and more questions to answer.
    Bourdon JC; Laurenzi VD; Melino G; Lane D
    Cell Death Differ; 2003 Apr; 10(4):397-9. PubMed ID: 12719714
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A.
    Yu DS; Hsieh DS; Chang SY
    J Urol; 2003 Nov; 170(5):2031-5. PubMed ID: 14532847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p53 and apoptosis in carcinogenesis.
    Wang XW
    Anticancer Res; 1999; 19(6A):4759-71. PubMed ID: 10697590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nature of new markers of general pathology].
    Paponov VD; Paponov VV; Baĭdakova GV; Borisova AM; Mordovtsev VN
    Ter Arkh; 2002; 74(12):91-5. PubMed ID: 12577854
    [No Abstract]   [Full Text] [Related]  

  • 17. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in T98G glioblastoma cells by transfection of GML, a p53 target gene.
    Ueda K; Miyoshi Y; Tokino T; Watatani M; Nakamura Y
    Oncol Res; 1999; 11(3):125-32. PubMed ID: 10527072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.